Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Unilife Corporation to Announce Financial Results for Fiscal Year 2016 Third Quarter on Monday, May 9, 2016

Conference Call Scheduled for 8:00 a.m. EDT on Monday, May 9, 2016

YORK, Pa., April 25, 2016 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the fiscal 2016 third quarter ended March 31, 2016 at 7:00 a.m. EDT on Monday, May 9, 2016.

Management has scheduled a conference call for 8:00 a.m. EDT on Monday, May 9, 2016 (Monday, May 9, 2016 at 10:00 p.m. AEST) to review the Company's financial results and provide an update on its customers and operating strategy. The conference call will be broadcast over the Internet as a "live" listen-only Webcast. To listen, please go to http://ir.unilife.com/events.cfm. Listeners are urged to log in approximately 20 minutes before the conference call is scheduled to begin in order to register, as well as to download and install any necessary audio software. An archive of the webcast will be available on the Company's website.

About Unilife Corporation

Unilife Corporation (NASDAQ:UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of injectable drug delivery systems. Unilife has a portfolio of innovative, differentiated products with a primary focus on wearable injectors. Products within each platform are customizable to address specific customer, drug and patient requirements. Unilife's global headquarters and manufacturing facilities are located in York, PA.  For more information, visit www.unilife.com.

General: UNIS-G

Investor Contact (US):
Jeremy Feffer
Unilife Corporation
+1-717-384-3450
investors@unilife.com

Investor Contact (Australia):
Jeff Carter
Unilife Corporation
+61 2 8346 6500

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/unilife-corporation-to-announce-financial-results-for-fiscal-year-2016-third-quarter-on-monday-may-9-2016-300256850.html

SOURCE Unilife Corporation



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today